Magnetic resonance imaging and histopathology of catheter ablation lesions after ventricular tachycardia ablation in patients with nonischemic cardiomyopathy.

Histopathology Late gadolinium enhancement cardiac magnetic resonance Nonischemic cardiomyopathy Radiofrequency catheter ablation Ventricular tachycardia

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
10 2022
Historique:
received: 24 04 2022
revised: 07 06 2022
accepted: 19 06 2022
pubmed: 1 7 2022
medline: 5 10 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

Late gadolinium enhanced cardiac magnetic resonance (LGE-CMR) imaging may help identify radiofrequency ablation lesions, which have been poorly described in patients with nonischemic cardiomyopathy (NICM). The purpose of this study was to describe LGE-CMR characteristics of ablation lesions in patients with NICM and correlate them with histopathology. Twenty-six patients (24 men; ejection fraction 38% ± 14%; age 61 ± 9 years) who had undergone CMR imaging after ventricular tachycardia (VT) ablation were included. Areas of both dark and bright core lesions correlating with previous radiofrequency ablation lesions were identified. Histology was performed on an explanted heart. Mean time between the ablation procedure and the LGE-CMR study was 8 [2-20] months. Twenty-three of 26 patients demonstrated dark core lesions (volume 2.16 ± 1.8 cm Ablation lesions can be detected by LGE-CMR after VT ablation in NICM patients and have a different appearance than scar tissue. These lesions can be observed in the acute and chronic settings after ablations.

Sections du résumé

BACKGROUND
Late gadolinium enhanced cardiac magnetic resonance (LGE-CMR) imaging may help identify radiofrequency ablation lesions, which have been poorly described in patients with nonischemic cardiomyopathy (NICM).
OBJECTIVES
The purpose of this study was to describe LGE-CMR characteristics of ablation lesions in patients with NICM and correlate them with histopathology.
METHODS
Twenty-six patients (24 men; ejection fraction 38% ± 14%; age 61 ± 9 years) who had undergone CMR imaging after ventricular tachycardia (VT) ablation were included. Areas of both dark and bright core lesions correlating with previous radiofrequency ablation lesions were identified. Histology was performed on an explanted heart.
RESULTS
Mean time between the ablation procedure and the LGE-CMR study was 8 [2-20] months. Twenty-three of 26 patients demonstrated dark core lesions (volume 2.16 ± 1.8 cm
CONCLUSION
Ablation lesions can be detected by LGE-CMR after VT ablation in NICM patients and have a different appearance than scar tissue. These lesions can be observed in the acute and chronic settings after ablations.

Identifiants

pubmed: 35772697
pii: S1547-5271(22)02156-7
doi: 10.1016/j.hrthm.2022.06.027
pii:
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1642-1649

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Michael Ghannam (M)

Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.

Jackson J Liang (JJ)

Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.

Anil Attili (A)

Department of Radiology, University of Michigan, Ann Arbor, Michigan.

Hubert Cochet (H)

Bordeaux University Hospital and University of Bordeaux, Bordeaux, France; INRIA, Sophia Antipolis, France.

Pierre Jais (P)

Bordeaux University Hospital and University of Bordeaux, Bordeaux, France; INRIA, Sophia Antipolis, France.

Rakesh Latchamsetty (R)

Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.

Krit Jongnarangsin (K)

Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.

Fred Morady (F)

Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.

David Gordon (D)

Department of Pathology, University of Michigan, Ann Arbor, Michigan.

Frank Bogun (F)

Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: fbogun@umich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH